RMC No. 5-2022
REVENUE MEMORANDUM CIRCULAR NO. 5-2022 issued on January 17, 2022 publishes the letter from Director General Rolando Enrique D. Domingo of the Food and Drug Administration endorsing the copy of the “Corrigendum to the ListRMC No. 5-2022